Global Surface Plasmon Resonance Market expected to reach $1,720.3 million by 2032

From GlobeNewswire: 2025-04-21 07:58:00

The global Surface Plasmon Resonance Market is expected to reach $1,720.3 million by 2032, with a CAGR of 6.5% from 2025. North America leads demand, while Latin America holds the second-largest market share. Asia Pacific is set for strong growth due to increased disease prevalence and clinical diagnostics.

The market growth is driven by rising drug discovery activities globally. Surface Plasmon Resonance technology is crucial for early-stage drug screening and biomolecular interaction analysis. However, high equipment costs and a shortage of skilled professionals pose challenges to market expansion.

The increasing incidence of chronic and infectious diseases is fueling demand for diagnostic tools like SPR-based biosensors. The technology is also gaining traction in food safety testing and environmental monitoring. Innovations in SPR technology, such as miniaturized sensors and AI integration, are enhancing market value.

Key developments in the industry include Carterra Inc.’s launch of Carterra Ultra for drug discovery applications and Bruker Corporation’s Triceratops SPR #64 Surface Plasmon System for molecular interaction analysis. Companies are also focusing on developing portable SPR devices and imaging systems with improved sensitivity.

The Drug Discovery Outsourcing Market is estimated to reach $6,685.1 million by 2032, with a CAGR of 6.4% from 2025. Similarly, the Drug Testing Market is expected to reach $21.50 billion by 2032, with a CAGR of 5.2% from 2025. These trends indicate significant growth opportunities in the pharmaceutical industry.



Read more at GlobeNewswire: Global Surface Plasmon Resonance Market to Reach $1,720.3